Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies

Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies

Designing and manufacturing safe and effective vaccines is a crucial challenge for human health worldwide. Research on adjuvant-based subunit vaccines is increasingly being explored to meet clinical needs. Nevertheless, the adaptive immune responses of subunit vaccines are still unfavorable, which m...

Full description

Bibliographic Details
Main Authors:	Yingying Hou, Min Chen, Yuan Bian, Xi Zheng, Rongsheng Tong, Xun Sun
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	Subunit vaccine Vaccine design Lymph node targeting Dendritic cell subset targeting B cell modulation Antigen cross-presentation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383523000060

Similar Items

Enhancing Protective Efficacy of Poultry Vaccines through Targeted Delivery of Antigens to Antigen-Presenting Cells
by: Angita Shrestha, et al.
Published: (2018-11-01)

Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection
by: Sudeep Kumar, et al.
Published: (2020-04-01)

Targeting dendritic cells in vivo for cancer therapy
by: Irina eCaminschi, et al.
Published: (2012-02-01)

Research Progress of Dendritic Cell Surface Receptors and Targeting
by: Chunyu Tong, et al.
Published: (2023-06-01)

Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines
by: Muhetaerjiang Mamuti, et al.
Published: (2023-01-01)

Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01)

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
by: Shinji Morisaki, et al.
Published: (2023-10-01)

Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines
by: Maarten K. Nijen Twilhaar, et al.
Published: (2021-06-01)

Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
by: Ivan Y. Filin, et al.
Published: (2021-09-01)

Advances in Oral Subunit Vaccine Design
by: Hans Van der Weken, et al.
Published: (2020-12-01)

mRNA as a Therapeutics: Understanding mRNA Vaccines
by: Ferdi Oğuz, et al.
Published: (2022-03-01)

The role of XCR1 and its ligand XCL1 in antigen cross-presentation by murine and human dendritic cells
by: Richard A. Kroczek, et al.
Published: (2012-02-01)

Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes
by: Yusuke Kitazawa, et al.
Published: (2019-05-01)

Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
by: Christian H. K. Lehmann, et al.
Published: (2016-03-01)

A DNA-Modified Live Vaccine Prime–Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus
by: Cindy Bernelin-Cottet, et al.
Published: (2019-06-01)

Dendritic cell-based vaccine efficacy: aiming for hot spots
by: Gabriela Andrea Pizzurro, et al.
Published: (2015-03-01)

Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine
by: Edgar Alonso Melgoza-González, et al.
Published: (2023-03-01)

Corrigendum: Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine
by: Edgar Alonso Melgoza-González, et al.
Published: (2023-06-01)

Human adenovirus type 7 subunit vaccine induces dendritic cell maturation through the TLR4/NF-κB pathway is highly immunogenic
by: Yaru Li, et al.
Published: (2023-04-01)

Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
by: Alexey V. Baldin, et al.
Published: (2020-03-01)

Utilizing murine dendritic cell line DC2.4 to evaluate the immunogenicity of subunit vaccines in vitro
by: Lantian Lu, et al.
Published: (2024-02-01)

DC-Based Vaccines for Cancer Immunotherapy
by: Chunmei Fu, et al.
Published: (2020-11-01)

Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy
by: Takashi Morisaki, et al.
Published: (2022-05-01)

A novel SARS-CoV-2 subunit vaccine engineered on an immune-activating platform technology
by: Edward J. Quinlan, et al.
Published: (2022-11-01)

Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies
by: Jianmei W. Leavenworth, et al.
Published: (2022-09-01)

Adjuvants and Antigen-Delivery Systems for Subunit Vaccines against Tuberculosis
by: Abu Salim Mustafa
Published: (2021-08-01)

Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
by: Soledad eMac Keon, et al.
Published: (2015-05-01)

Lentiviral Vectors as a Vaccine Platform against Infectious Diseases
by: Kirill Nemirov, et al.
Published: (2023-03-01)

The known unknowns of the human dendritic cell network
by: Mélanie eDurand, et al.
Published: (2015-03-01)

Recent advancements in combination subunit vaccine development
by: Ming Tan, et al.
Published: (2017-01-01)

Stable contacts of naïve CD4 T cells with migratory dendritic cells are ICAM-1-dependent but dispensable for proliferation in vivo
by: Stav Kozlovski, et al.
Published: (2019-01-01)

Understanding the biology of antigen cross-presentation for the design of vaccines against cancer
by: Cynthia M. Fehres, et al.
Published: (2014-04-01)

Approaches to Improve Chemically Defined Synthetic Peptide Vaccines
by: Brett J. Hos, et al.
Published: (2018-04-01)

Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone
by: Aneesh Thakur, et al.
Published: (2020-05-01)

Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes
by: Obermaier Bianca, et al.
Published: (2003-01-01)

Vaccine delivery using nanoparticles
by: Anthony Edward Gregory, et al.
Published: (2013-03-01)

Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy
by: Lukas Amon, et al.
Published: (2020-07-01)

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses
by: Reem Ghinnagow, et al.
Published: (2017-09-01)

Editorial: Harnessing the Participation of Dendritic Cells in Immunity and Tolerance
by: Silvia Beatriz Boscardin, et al.
Published: (2020-10-01)

CD14 Expressing Precursors Give Rise to Highly Functional Conventional Dendritic Cells for Use as Dendritic Cell Vaccine
by: Maud Plantinga, et al.
Published: (2021-07-01)